Mass balance and metabolite profiling of 14C-guadecitabine in patients with advanced cancer
Sign Up to like & getrecommendations! Published in 2019 at "Investigational New Drugs"
DOI: 10.1007/s10637-019-00854-9
Abstract: Purpose The objective of this mass balance trial was to determine the excretory pathways and metabolic profile of the novel anticancer agent guadecitabine in humans after administration of a 14C-radiolabeled dose of guadecitabine. Experimental design… read more here.
Keywords: mass balance; guadecitabine; 14c guadecitabine; mass ... See more keywords